Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial

P. N. Harden; J. M. Hoogendijk-van den Akker; J. N. Bouwes-Bavinck; C. M. Proby; A. J. Hoitsma; R. Wolterbeck; J. W. de Fifter

doi:10.1111/j.1432-2277.2011.01346.x

Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial

P. N. Harden, J. M. Hoogendijk-van den Akker, J. N. Bouwes-Bavinck, C. M. Proby, A. J. Hoitsma, R. Wolterbeck, J. W. de Fifter

Research output: Contribution to journal › Special issue › peer-review

Original language	English
Article number	LB-O-006
Pages (from-to)	94-95
Number of pages	2
Journal	Transplant International
Volume	24
Issue number	S2
DOIs	https://doi.org/10.1111/j.1432-2277.2011.01346.x
Publication status	Published - 2011
Event	15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics (BSHI) - Glasgow, United Kingdom Duration: 4 Sept 2011 → 7 Sept 2011

Access to Document

10.1111/j.1432-2277.2011.01346.x

Cite this

Harden, P. N., Hoogendijk-van den Akker, J. M., Bouwes-Bavinck, J. N., Proby, C. M., Hoitsma, A. J., Wolterbeck, R., & de Fifter, J. W. (2011). Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial. Transplant International, 24(S2), 94-95. Article LB-O-006. https://doi.org/10.1111/j.1432-2277.2011.01346.x

@article{5d5382bf354645bd8a9ec4f5bde00f11,

title = "Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial",

author = "Harden, {P. N.} and {Hoogendijk-van den Akker}, {J. M.} and Bouwes-Bavinck, {J. N.} and Proby, {C. M.} and Hoitsma, {A. J.} and R. Wolterbeck and {de Fifter}, {J. W.}",

year = "2011",

doi = "10.1111/j.1432-2277.2011.01346.x",

language = "English",

volume = "24",

pages = "94--95",

journal = "Transplant International",

issn = "0934-0874",

publisher = "Frontiers Media SA",

number = "S2",

note = "15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics (BSHI) ; Conference date: 04-09-2011 Through 07-09-2011",

}

Harden, PN, Hoogendijk-van den Akker, JM, Bouwes-Bavinck, JN, Proby, CM, Hoitsma, AJ, Wolterbeck, R & de Fifter, JW 2011, 'Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial', Transplant International, vol. 24, no. S2, LB-O-006, pp. 94-95. https://doi.org/10.1111/j.1432-2277.2011.01346.x

Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial. / Harden, P. N.; Hoogendijk-van den Akker, J. M.; Bouwes-Bavinck, J. N. et al.
In: Transplant International, Vol. 24, No. S2, LB-O-006, 2011, p. 94-95.

Research output: Contribution to journal › Special issue › peer-review

TY - JOUR

T1 - Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial

AU - Harden, P. N.

AU - Hoogendijk-van den Akker, J. M.

AU - Bouwes-Bavinck, J. N.

AU - Proby, C. M.

AU - Hoitsma, A. J.

AU - Wolterbeck, R.

AU - de Fifter, J. W.

PY - 2011

Y1 - 2011

U2 - 10.1111/j.1432-2277.2011.01346.x

DO - 10.1111/j.1432-2277.2011.01346.x

M3 - Special issue

SN - 0934-0874

VL - 24

SP - 94

EP - 95

JO - Transplant International

JF - Transplant International

IS - S2

M1 - LB-O-006

T2 - 15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics (BSHI)

Y2 - 4 September 2011 through 7 September 2011

ER -

Harden PN, Hoogendijk-van den Akker JM, Bouwes-Bavinck JN, Proby CM, Hoitsma AJ, Wolterbeck R et al. Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial. Transplant International. 2011;24(S2):94-95. LB-O-006. doi: 10.1111/j.1432-2277.2011.01346.x